Vyant Bio Inc Asset Turnover Ratio (VYNT), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vyant Bio Inc   (NASDAQ: VYNT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Vyant Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vyant Bio Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.03 in the fourth quarter (Dec 31 2022)

Within sector 42 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 0 to 4171.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VYNT Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change -61.17 % -62.37 % -60.3 % -55.08 % 350.84 %
Y / Y Revenue Change -87.22 % -89.91 % -91.53 % 36.49 % -72.54 %
Asset Turnover Ratio (TTM) 0.03 0.03 0.06 0.08 0.07
VYNT's Total Ranking # 4171 # 0 # 0 # 4623 # 4159
Seq. Asset Change -36.56 % -11.27 % -20.1 % -13.65 % -38.52 %
Seq. Revenue Change -69.74 % -7.88 % -45.54 % -15.83 % -76.1 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 43
Healthcare Sector # 660
Overall Market # 4171

Asset Turnover Ratio Statistics
High Average Low
5.09 2.43 -4.04
(Jun 30 2021)   (Sep 30 2022)




VYNT Company Profile • Back to VYNT Efficiency Comparisons • Compare VYNT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Sigilon Therapeutics Inc   0.12 $ 12.944  Millions$ 103.870  Millions
Fate Therapeutics Inc   0.12 $ 96.300  Millions$ 780.089  Millions
Genfit S a   0.12 $ 29.754  Millions$ 243.095  Millions
Regenxbio Inc   0.12 $ 112.724  Millions$ 923.968  Millions
2seventy Bio Inc   0.12 $ 91.496  Millions$ 751.184  Millions
Alpine Immune Sciences Inc   0.12 $ 30.064  Millions$ 257.012  Millions
Vectivbio Holding Ag  0.12 $ 27.341  Millions$ 233.952  Millions
Scisparc Ltd  0.12 $ 1.347  Millions$ 11.559  Millions
Morphosys Ag  0.12 $ 311.659  Millions$ 2,684.564  Millions
Aclaris Therapeutics Inc   0.12 $ 29.752  Millions$ 256.683  Millions
Regenerx Biopharmaceuticals inc   0.12 $ 0.077  Millions$ 0.665  Millions
Isoplexis Corporation  0.12 $ 16.528  Millions$ 143.250  Millions
Comera Life Sciences Holdings Inc   0.11 $ 0.633  Millions$ 5.553  Millions
Inspira Technologies Oxy B H N Ltd  0.11 $ 1.951  Millions$ 17.234  Millions
Lineage Cell Therapeutics Inc   0.11 $ 14.703  Millions$ 133.814  Millions
Impel Pharmaceuticals Inc   0.11 $ 12.652  Millions$ 115.489  Millions
Nektar Therapeutics  0.11 $ 92.055  Millions$ 844.427  Millions
Edgemode Inc   0.11 $ 0.438  Millions$ 4.044  Millions
Inmed Pharmaceuticals Inc  0.11 $ 1.615  Millions$ 14.944  Millions
Galapagos Nv  0.11 $ 565.914  Millions$ 5,302.473  Millions
Sinovac Biotech Ltd  0.11 $ 1,492.761  Millions$ 14,093.562  Millions
Xenetic Biosciences Inc   0.11 $ 1.707  Millions$ 16.186  Millions
Inventiva S a   0.10 $ 13.640  Millions$ 129.924  Millions
Bridgebio Pharma Inc   0.10 $ 77.648  Millions$ 756.790  Millions
Icecure Medical Ltd  0.10 $ 3.085  Millions$ 30.188  Millions
Cytokinetics Incorporated  0.10 $ 94.588  Millions$ 929.677  Millions
Precision Biosciences Inc  0.10 $ 25.098  Millions$ 247.104  Millions
Merus N v   0.10 $ 41.586  Millions$ 413.456  Millions
Theravance Biopharma inc   0.10 $ 51.346  Millions$ 521.754  Millions
Sorrento Therapeutics Inc   0.10 $ 62.840  Millions$ 644.055  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.